Sofosbuvir/Ravidasvir Combination Therapy Phase II/III
NCT02961426 | Malaysia, Thailand
This is a multicentre, multi-country, trial to assess the efficacy, safety, tolerance, and pharmacokinetics of sofosbuvir plus ravidasvir for the treatment of HCV infection.
Ravidasvir Phase I
NCT03602300 | Malaysia
Open-label, crossover study to evaluate the relative bioavailability of a tablet formulation of ravidasvir versus the capsule formulation of ravidasvir in healthy adult subjects.
Last update: September 2018